indianpharmapost: political leaning and recent coverage
United One News classifies indianpharmapost as center. This rating is an automated estimate and has not been reviewed yet.
7 live stories tracked on United One News.
Recent coverage
- Novo Nordisk raises 2026 outlook after stronger-than-expected Q3 driven by obesity drug sales —
- AstraZeneca to Launch New Cancer Drug Line in Russia —
- CCI Approves Kotak Mahindra Acquisition of Deutsche Bank India Assets —
- Emcure Pharma Maintained at Buy by Jefferies and Kotak —
- Glenmark Pharmaceuticals elevates Namita Shah to Sr. VP – Global Portfolio —
- Saving more children from cancer: India’s push to reach 60% survival by 2030 —
- Syngene reports 13% sequential revenue growth in second quarter —
- Jagsonpal Pharmaceuticals Q2 FY27 Revenue Climbs 29% to ₹964 Crore —
- Abbott to spin off $8.5 billion nutrition business into independent public company —